Results 221 to 230 of about 38,327 (259)

Management of Heparin-Induced Thrombocytopenia: A Contemporary Review. [PDF]

J Clin Med
Ng JY, D'Souza M, Hutani F, Choi P.
europepmc   +1 more source

Heparin induced thrombocytopenia-type 2

Asian Journal of Transfusion Science, 2010
Majeed Tanveer
doaj  

Some of the next articles are maybe not open access.

Related searches:

Heparin-induced thrombocytopenia

Hämostaseologie, 2010
SummaryHeparin-induced thrombocytopenia (HIT), typically occurring in the second week of heparin therapy, is an antibody-mediated adverse drug reaction associated with increased thrombotic risk. The most important antigens are located on platelet factor 4 (PF4)/heparin complexes.
A, Greinacher, K, Althaus, K, Krauel, S, Selleng   +3 more
exaly   +6 more sources

Heparin induced thrombocytopenia

BMJ, 2015
This clinical review has been developed for The BMJ in collaboration with BMJ Best Practice, based on a regularly updated web/mobile topic that supports evidence based decision making at the point of care. To view the complete and current version, please refer to the heparin induced thrombocytopenia (http://bestpractice.bmj.com/best-practice/monograph ...
Andreas Greinacher
exaly   +6 more sources

Heparin-Induced Immune Thrombocytopenia

New England Journal of Medicine, 1976
We studied five patients in whom severe thrombocytopenia developed during intermittent intravenous heparin treatment of arterial and venous thrombosis. Platelet aggregation was demonstrated when heparin (0.5 U per milliliter) was incubated with the patients' citrated platelet-rich plasma or with normal platelet-rich plasma in the presence of the ...
R B, Babcock, C W, Dumper, W B, Scharfman   +2 more
openaire   +4 more sources

Heparin-Induced Thrombocytopenia

International Anesthesiology Clinics, 2004
Heparin is widely used for the prevention and treatment of thrombotic and particularly cardiovascular disorders. Unfortunately, 0.5 to 3.0% of patients given heparin develop an immune reaction, commonly termed Type II heparin-induced thrombocytopenia (HIT).
Mark E, Comunale, Elizabeth M, Van Cott
openaire   +4 more sources

Heparin-induced Thrombocytopenia

Pathophysiology of Haemostasis and Thrombosis, 1986
Heparin-induced thrombocytopenia is the most frequent and the most important idiosyncratic haematological drug reaction. It is important for several reasons: first, because heparin is used so often, and the frequency of heparin-induced thrombocytopenia is high, the risk of a hospitalized patient developing heparin-induced thrombocytopenia is high ...
J G, Kelton, M N, Levine
openaire   +4 more sources

Heparin–induced thrombocytopenia

American Journal of Health-System Pharmacy, 1995
Heparin is one of the most frequently prescribed medications in the United States with more than 1 trillion units being used each year. However, some patients who receive heparin may have development of a rare but severe complication called heparin-induced thrombocytopenia, which is associated with significant morbidity and mortality rates.
D A, Borkowski, R W, Force
openaire   +4 more sources

HEPARIN‐INDUCED THROMBOCYTOPENIA

BJU International, 2007
Each year, 25% of all hospitalized patients are affected by venous thromboembolism, a disease comprising deep vein thrombosis and pulmonary embolism, that is responsible for up to 10% of all inpatient deaths (Alikhan, Peters, Wilmott, Cohen, 2004). Used in both the treatment and the prevention of venous thromboembolism, heparin is administered to more ...
openaire   +4 more sources

Heparin-Induced Thrombocytopenia

Australian and New Zealand Journal of Medicine, 1988
Abstract:Thrombocytopenia is a common adverse effect of heparin therapy. Two types of heparinlinduced thrombocytopenia (HIT) are observed clinically ‐ an early onset mild thrombocytopenia (Type I) in which the patients remain asymptomatic and a delayed onset severe thrombocytopenia (Type II).
openaire   +5 more sources